Standardized Chemical Allergen [EPC]

Standardized Chemical Allergen [EPC] was reported 77387 times

Drugs of the Standardized Chemical Allergen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GRIP STRENGTH 123 0.5371
1 HEPATIC ENZYME 80 0.5369
2 VAGINAL FLATULENCE 136 0.4488
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 286 0.4281
4 RHEUMATOID FACTOR NEGATIVE 73 0.4171
5 LUPUS VULGARIS 517 0.4103
6 SYNOVIAL FLUID ANALYSIS 35 0.4023
7 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 193 0.3440
8 FACET JOINT SYNDROME 1105 0.3391
9 SWOLLEN JOINT COUNT 80 0.3200
10 RHEUMATIC FEVER 1408 0.3156
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 606 0.3025
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 626 0.3018
13 SWOLLEN JOINT COUNT INCREASED 923 0.2892
14 X-RAY ABNORMAL 494 0.2760
15 DISLOCATION OF VERTEBRA 618 0.2707
16 C-REACTIVE PROTEIN 247 0.2665
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1857 0.2589
18 RHEUMATOID FACTOR POSITIVE 1488 0.2574
19 DUODENAL ULCER PERFORATION 1769 0.2376
20 ANKLE ARTHROPLASTY 86 0.2369
21 C-REACTIVE PROTEIN ABNORMAL 1512 0.2355
22 ANTACID THERAPY 29 0.2231
23 RETINITIS 376 0.2175
24 CYTOLOGY ABNORMAL 31 0.2067
25 PERIPHERAL VENOUS DISEASE 810 0.1981
26 INTESTINAL SEPSIS 51 0.1947
27 MUSCLE INJURY 1582 0.1907
28 HELICOBACTER INFECTION 1909 0.1856
29 HAND DEFORMITY 2320 0.1767
30 FOLLICULITIS 1843 0.1756
31 GRANULOMA SKIN 143 0.1742
32 HYPOCHOLESTEROLAEMIA 61 0.1728
33 PORPHYRIA ACUTE 244 0.1700
34 RED BLOOD CELL SEDIMENTATION RATE 47 0.1685
35 PRESBYACUSIS 51 0.1656
36 PEMPHIGUS 2051 0.1639
37 DEAFNESS TRANSITORY 131 0.1534
38 SLEEP DISORDER THERAPY 30 0.1515
39 BREAST CANCER STAGE III 971 0.1498
40 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 966 0.1486
41 BONE EROSION 511 0.1444
42 RHEUMATOID LUNG 132 0.1382
43 BLOOD IRON ABNORMAL 135 0.1382
44 ONYCHOMADESIS 576 0.1371
45 SYNOVITIS 2422 0.1342
46 CONGENITAL HIATUS HERNIA 30 0.1316
47 LIP DRY 1131 0.1244
48 DRUG TOLERANCE DECREASED 341 0.1213
49 GRIP STRENGTH DECREASED 1041 0.1182
50 JOINT RANGE OF MOTION DECREASED 1578 0.1175
51 NONALCOHOLIC FATTY LIVER DISEASE 23 0.1173
52 HYPERCHOLESTEROLAEMIA 1126 0.1165
53 SERONEGATIVE ARTHRITIS 130 0.1134
54 ONYCHOMYCOSIS 496 0.1129
55 PERICARDITIS 1885 0.1121
56 BLOOD PARATHYROID HORMONE DECREASED 162 0.1092
57 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 244 0.1058
58 MALIGNANT MELANOMA STAGE 0 22 0.1053
59 ANTICOAGULANT THERAPY 29 0.1021
60 MICROSPORIDIA INFECTION 35 0.0997
61 ANALGESIC THERAPY 32 0.0997
62 DRUG THERAPY 32 0.0944
63 GLOSSODYNIA 2087 0.0931
64 WOUND INFECTION 1005 0.0917
65 CAPILLARITIS 25 0.0906
66 BLEPHAROSPASM 560 0.0888
67 FEMALE GENITAL TRACT FISTULA 150 0.0878
68 BURSITIS 1050 0.0865
69 IRRITABLE BOWEL SYNDROME 1853 0.0863
70 FINGER DEFORMITY 417 0.0860
71 RED BLOOD CELL SEDIMENTATION RATE INCREASED 943 0.0851
72 RHEUMATOID NODULE 233 0.0845
73 CONTRAINDICATED PRODUCT ADMINISTERED 2427 0.0801
74 NAIL DISORDER 698 0.0797
75 TENOSYNOVITIS 220 0.0797
76 PLEURAL THICKENING 53 0.0775
77 METHAEMOGLOBINAEMIA 178 0.0768
78 GAIT SPASTIC 26 0.0758
79 LIVE BIRTH 623 0.0744
80 PULMONARY VASCULITIS 40 0.0743
81 TENOSYNOVITIS STENOSANS 41 0.0736
82 FIBROMYALGIA 1766 0.0726
83 JOINT DESTRUCTION 110 0.0707
84 TOTAL LUNG CAPACITY ABNORMAL 27 0.0694
85 PANNICULITIS 165 0.0681
86 WOUND 1889 0.0675
87 SPIROMETRY ABNORMAL 40 0.0669
88 PRODUCT LABEL CONFUSION 377 0.0646
89 MITE ALLERGY 42 0.0641
90 SYNOVIAL DISORDER 29 0.0637
91 SOFT TISSUE SWELLING 36 0.0634
92 NECK DEFORMITY 28 0.0631
93 AUTOIMMUNE DISORDER 606 0.0621
94 OVERLAP SYNDROME 43 0.0614
95 PULMONARY FIBROSIS 1158 0.0603
96 BLOOD MAGNESIUM INCREASED 53 0.0588
97 ALLERGY TO CHEMICALS 73 0.0586
98 OBESITY 927 0.0581
99 PUSTULAR PSORIASIS 198 0.0576
100 SYSTEMIC LUPUS ERYTHEMATOSUS 2036 0.0573
101 NEEDLE FATIGUE 26 0.0569
102 LIVER INJURY 1395 0.0568
103 IMPAIRED HEALING 1863 0.0567
104 RADICULOPATHY 147 0.0557
105 SCIATICA 874 0.0548
106 ARTHROPATHY 3034 0.0545
107 APPENDICOLITH 21 0.0543
108 WALKING AID USER 351 0.0532
109 MYCOTIC ALLERGY 45 0.0526
110 BLOOD IMMUNOGLOBULIN M INCREASED 32 0.0526
111 PLEURAL FIBROSIS 53 0.0520
112 MATERNAL EXPOSURE TIMING UNSPECIFIED 195 0.0519
113 PROCTITIS 140 0.0499
114 LARYNGEAL DISORDER 36 0.0499
115 ALLERGY TO METALS 30 0.0494
116 TYPE 2 DIABETES MELLITUS 1661 0.0493
117 EXOSTOSIS 450 0.0492
118 BLOOD IMMUNOGLOBULIN A DECREASED 32 0.0492
119 PSORIATIC ARTHROPATHY 1973 0.0486
120 FOOT DEFORMITY 535 0.0482
121 THERAPEUTIC PRODUCT EFFECT DECREASED 2089 0.0466
122 LUPUS-LIKE SYNDROME 420 0.0463
123 COELIAC DISEASE 449 0.0457
124 CONGENITAL ANOMALY 350 0.0452
125 DRUG TOLERANCE 228 0.0450
126 CHRONIC SINUSITIS 168 0.0447
127 ULCER HAEMORRHAGE 302 0.0446
128 SHOULDER ARTHROPLASTY 120 0.0445
129 DUST ALLERGY 43 0.0438
130 EYE INJURY 132 0.0434
131 JOINT ARTHROPLASTY 77 0.0430
132 BACK INJURY 466 0.0428
133 APPARENT DEATH 153 0.0424
134 ENTHESOPATHY 66 0.0422
135 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 30 0.0409
136 RASH VESICULAR 198 0.0409
137 WRIST DEFORMITY 25 0.0407
138 LOWER RESPIRATORY TRACT INFECTION 1831 0.0402
139 C-REACTIVE PROTEIN INCREASED 1409 0.0387
140 RHEUMATOID ARTHRITIS 4289 0.0377
141 ADVERSE REACTION 492 0.0371
142 DEATH NEONATAL 49 0.0352
143 INFUSION SITE REACTION 105 0.0351
144 BREAST CANCER STAGE II 289 0.0347
145 INFUSION RELATED REACTION 2293 0.0346
146 BLOOD CHOLESTEROL INCREASED 1601 0.0343
147 GAIT INABILITY 1145 0.0342
148 PULMONARY TOXICITY 240 0.0339
149 LOWER LIMB FRACTURE 648 0.0337
150 PRESCRIBED UNDERDOSE 667 0.0334
151 LIP ULCERATION 39 0.0334
152 SYNOVIAL CYST 154 0.0333
153 FOOT OPERATION 165 0.0333
154 SKIN NEOPLASM EXCISION 26 0.0332
155 PRESCRIBED OVERDOSE 636 0.0328
156 STOMATITIS 1992 0.0328
157 OSTEOARTHRITIS 1379 0.0325
158 HEPATIC ENZYME INCREASED 2203 0.0323
159 DRUG INTOLERANCE 3118 0.0322
160 LIVER FUNCTION TEST INCREASED 687 0.0320
161 RELAPSING-REMITTING MULTIPLE SCLEROSIS 27 0.0312
162 BONE CYST 29 0.0309
163 BLISTER 1736 0.0309
164 SKIN NECROSIS 157 0.0302
165 INFLAMMATION 1536 0.0297
166 JOINT SWELLING 3586 0.0297
167 NIGHT SWEATS 951 0.0295
168 FUNCTIONAL GASTROINTESTINAL DISORDER 101 0.0292
169 HIP ARTHROPLASTY 445 0.0290
170 ILL-DEFINED DISORDER 1761 0.0290
171 SOFT TISSUE DISORDER 32 0.0289
172 TREATMENT FAILURE 2379 0.0287
173 NEURITIS 44 0.0285
174 CONJUNCTIVITIS ALLERGIC 42 0.0283
175 MOBILITY DECREASED 2037 0.0283
176 GASTROINTESTINAL TOXICITY 135 0.0281
177 SPONDYLITIS 101 0.0277
178 JOINT DISLOCATION 290 0.0274
179 RHEUMATIC DISORDER 53 0.0274
180 BLOOD IMMUNOGLOBULIN G INCREASED 33 0.0271
181 LOSS OF EMPLOYMENT 82 0.0271
182 SLEEP DISORDER 1904 0.0269
183 TASTE DISORDER 546 0.0269
184 WRIST SURGERY 25 0.0267
185 EPIDERMAL NECROSIS 26 0.0267
186 DEMYELINATION 109 0.0266
187 PRERENAL FAILURE 37 0.0262
188 SCLERITIS 42 0.0262
189 ALANINE AMINOTRANSFERASE ABNORMAL 55 0.0261
190 PNEUMOCYSTIS JIROVECII INFECTION 31 0.0259
191 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 24 0.0259
192 MUSCULOSKELETAL PAIN 1340 0.0256
193 WHEEZING 1507 0.0254
194 NORMAL NEWBORN 138 0.0254
195 HEPATIC CIRRHOSIS 475 0.0253
196 SWELLING 2335 0.0249
197 PLEURITIC PAIN 68 0.0246
198 EPISCLERITIS 17 0.0246
199 INJURY 1730 0.0246
200 MUSCULOSKELETAL STIFFNESS 2145 0.0245
201 BREATH SOUNDS ABNORMAL 118 0.0239
202 RESPIRATORY SYMPTOM 68 0.0239
203 NEOPLASM SKIN 37 0.0238
204 KNEE ARTHROPLASTY 500 0.0237
205 GENERAL SYMPTOM 175 0.0233
206 DISCOMFORT 1416 0.0232
207 MYOSITIS 206 0.0229
208 LUNG DISORDER 1113 0.0227
209 LIMB DEFORMITY 36 0.0226
210 DRUG-INDUCED LIVER INJURY 707 0.0225
211 JOINT STIFFNESS 589 0.0224
212 PRURITUS ALLERGIC 26 0.0223
213 LIVER DISORDER 970 0.0219
214 FINE MOTOR SKILL DYSFUNCTION 63 0.0217
215 TUBERCULIN TEST POSITIVE 55 0.0217
216 PNEUMONIA VIRAL 69 0.0216
217 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 44 0.0216
218 POLYARTHRITIS 113 0.0214
219 SPINAL STENOSIS 88 0.0213
220 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 51 0.0206
221 GASTROINTESTINAL DISORDER 1824 0.0203
222 EPILEPSY 621 0.0203
223 TERMINAL STATE 135 0.0202
224 CREPITATIONS 60 0.0201
225 OEDEMA 1091 0.0201
226 EAR INFECTION 535 0.0201
227 NODULE 254 0.0194
228 DISABILITY 384 0.0194
229 ROAD TRAFFIC ACCIDENT 812 0.0194
230 SPINAL FUSION SURGERY 78 0.0192
231 HEPATITIS 484 0.0189
232 THERAPY NON-RESPONDER 830 0.0184
233 DELIRIUM 633 0.0182
234 WHEELCHAIR USER 81 0.0182
235 MACULAR DEGENERATION 217 0.0182
236 TENDERNESS 187 0.0179
237 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 304 0.0179
238 OSTEOSCLEROSIS 28 0.0178
239 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 303 0.0177
240 VIRAL UPPER RESPIRATORY TRACT INFECTION 84 0.0177
241 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1248 0.0175
242 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 827 0.0172
243 GRANULOMA 59 0.0170
244 DEAFNESS NEUROSENSORY 56 0.0170
245 FREQUENT BOWEL MOVEMENTS 454 0.0168
246 HYPERPHOSPHATAEMIA 36 0.0167
247 GENERAL PHYSICAL HEALTH DETERIORATION 1935 0.0167
248 NORMOCHROMIC NORMOCYTIC ANAEMIA 50 0.0166
249 INTENTIONAL PRODUCT USE ISSUE 1440 0.0164
250 PHARYNGITIS 200 0.0161
251 GASTROINTESTINAL PAIN 174 0.0158
252 INFECTION 2273 0.0157
253 SINUSITIS 1593 0.0155
254 MATERNAL EXPOSURE DURING PREGNANCY 1370 0.0154
255 PERIPHERAL SWELLING 2361 0.0153
256 ABDOMINAL DISCOMFORT 2558 0.0152
257 DRY MOUTH 1218 0.0150
258 VAGINAL DISCHARGE 151 0.0149
259 MONOPARESIS 27 0.0149
260 ULCER 237 0.0149
261 EPIGASTRIC DISCOMFORT 58 0.0148
262 MUSCULOSKELETAL DISORDER 282 0.0148
263 CONTUSION 1391 0.0144
264 DYSPEPSIA 1416 0.0144
265 ANTINUCLEAR ANTIBODY POSITIVE 46 0.0141
266 CUSHINGOID 45 0.0140
267 PULMONARY THROMBOSIS 152 0.0139
268 NECK MASS 39 0.0138
269 HYPERCALCAEMIA 166 0.0134
270 HYPERSENSITIVITY 2444 0.0132
271 ROTATOR CUFF REPAIR 23 0.0131
272 BACK DISORDER 211 0.0130
273 PARAESTHESIA ORAL 186 0.0129
274 MULTIPLE ALLERGIES 101 0.0129
275 MIGRAINE 1216 0.0127
276 PREGNANCY 250 0.0125
277 SKIN ULCER 317 0.0123
278 ORAL CANDIDIASIS 161 0.0122
279 EXPOSURE DURING PREGNANCY 756 0.0122
280 CONFUSIONAL STATE 1939 0.0120
281 BASAL CELL CARCINOMA 187 0.0120
282 JOINT INJURY 250 0.0117
283 HYPOAESTHESIA 1748 0.0117
284 ARTHRITIS 907 0.0115
285 HYPERTONIC BLADDER 33 0.0114
286 SENSITIVITY TO WEATHER CHANGE 60 0.0114
287 BLOOD PHOSPHORUS INCREASED 31 0.0113
288 URTICARIA 1895 0.0113
289 ABNORMAL LOSS OF WEIGHT 77 0.0113
290 DRUG ERUPTION 198 0.0112
291 DEFORMITY 104 0.0111
292 ALOPECIA 2181 0.0111
293 HYPERTENSION 2346 0.0111
294 AMNESIA 708 0.0109
295 COMA SCALE ABNORMAL 31 0.0107
296 NASOPHARYNGITIS 1962 0.0106
297 HEPATIC ENZYME ABNORMAL 53 0.0106
298 IMMUNODEFICIENCY 158 0.0106
299 GASTROOESOPHAGEAL REFLUX DISEASE 846 0.0105
300 NEUROLOGICAL SYMPTOM 60 0.0105
301 MILIARIA 18 0.0105
302 NECK PAIN 577 0.0103
303 FORCED EXPIRATORY VOLUME DECREASED 29 0.0102
304 ADRENAL INSUFFICIENCY 123 0.0101
305 WEIGHT FLUCTUATION 106 0.0101
306 PHOTOSENSITIVITY REACTION 167 0.0101
307 OSTEOPOROSIS 409 0.0099
308 RECTAL HAEMORRHAGE 423 0.0098
309 CONDITION AGGRAVATED 2979 0.0098
310 JOINT EFFUSION 67 0.0097
311 TONGUE DISORDER 70 0.0097
312 EAR PAIN 188 0.0097
313 COLITIS ULCERATIVE 430 0.0096
314 DIVERTICULITIS 265 0.0096
315 MEMORY IMPAIRMENT 1308 0.0095
316 ANKYLOSING SPONDYLITIS 125 0.0095
317 FEAR OF INJECTION 67 0.0094
318 VITAMIN B12 DECREASED 27 0.0094
319 COLITIS MICROSCOPIC 44 0.0093
320 RESPIRATORY DISORDER 277 0.0092
321 IRON DEFICIENCY 41 0.0091
322 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 46 0.0091
323 MUSCULAR WEAKNESS 1020 0.0090
324 HEPATIC STEATOSIS 166 0.0089
325 WEIGHT INCREASED 1981 0.0088
326 IMPAIRED GASTRIC EMPTYING 119 0.0087
327 ADVERSE EVENT 796 0.0086
328 HEPATOTOXICITY 192 0.0086
329 ALCOHOL POISONING 23 0.0086
330 VASCULITIS 100 0.0086
331 MUSCLE SPASTICITY 105 0.0085
332 UPPER RESPIRATORY TRACT INFECTION 392 0.0085
333 SPINAL COLUMN STENOSIS 40 0.0085
334 SKIN LACERATION 92 0.0085
335 ARTHRALGIA 3496 0.0084
336 ABDOMINAL PAIN UPPER 1713 0.0083
337 INJECTION SITE REACTION 568 0.0082
338 THERAPEUTIC RESPONSE DECREASED 499 0.0082
339 THERAPEUTIC REACTION TIME DECREASED 24 0.0082
340 ARTERIOSCLEROSIS CORONARY ARTERY 54 0.0081
341 PRODUCT USE ISSUE 1528 0.0081
342 MEDICATION ERROR 444 0.0080
343 RASH PRURITIC 432 0.0080
344 JAW FRACTURE 17 0.0079
345 PULMONARY ALVEOLAR HAEMORRHAGE 44 0.0078
346 FEEDING DISORDER 159 0.0078
347 LABORATORY TEST ABNORMAL 230 0.0078
348 HYPERTRANSAMINASAEMIA 54 0.0078
349 BONE DENSITY ABNORMAL 29 0.0078
350 INSOMNIA 2018 0.0076
351 REGURGITATION 26 0.0076
352 DEAFNESS 197 0.0075
353 CHONDROPATHY 20 0.0074
354 GOITRE 30 0.0073
355 ULCERATIVE KERATITIS 20 0.0073
356 ASTHMA 822 0.0073
357 PNEUMONIA ASPIRATION 179 0.0072
358 RASH 3074 0.0070
359 PULMONARY MASS 105 0.0070
360 DRUG TOXICITY 96 0.0070
361 PARAESTHESIA 1107 0.0070
362 PAIN IN EXTREMITY 2054 0.0070
363 ADVERSE DRUG REACTION 620 0.0069
364 HYPOPHAGIA 176 0.0069
365 PARADOXICAL DRUG REACTION 25 0.0068
366 STENT PLACEMENT 54 0.0067
367 INTERSTITIAL LUNG DISEASE 323 0.0067
368 IMPAIRED WORK ABILITY 142 0.0066
369 MUSCLE SPASMS 1211 0.0066
370 DECREASED APPETITE 1522 0.0065
371 HANGOVER 23 0.0065
372 SARCOIDOSIS 31 0.0065
373 FULL BLOOD COUNT ABNORMAL 68 0.0064
374 VITAMIN B12 DEFICIENCY 26 0.0064
375 ABDOMINAL DISTENSION 669 0.0064
376 GASTROENTERITIS VIRAL 115 0.0064
377 OEDEMA PERIPHERAL 772 0.0063
378 RASH MACULO-PAPULAR 140 0.0063
379 LIMB OPERATION 30 0.0062
380 PAIN 3820 0.0062
381 FLANK PAIN 58 0.0062
382 SKIN WARM 36 0.0062
383 CHEST PAIN 1137 0.0061
384 TENDONITIS 95 0.0061
385 ASPIRATION 67 0.0061
386 GASTRIC DISORDER 207 0.0060
387 WHITE BLOOD CELL COUNT INCREASED 230 0.0060
388 CATARACT OPERATION 35 0.0059
389 BLOOD PRESSURE SYSTOLIC INCREASED 115 0.0059
390 LIMB DISCOMFORT 181 0.0058
391 SUSPECTED OFF LABEL USE 26 0.0057
392 OBSTRUCTIVE AIRWAYS DISORDER 64 0.0057
393 ARTERIOSCLEROSIS 54 0.0057
394 CYST 71 0.0057
395 HERPES ZOSTER 324 0.0056
396 DEPRESSION 1277 0.0056
397 PNEUMONIA 1812 0.0056
398 ATELECTASIS 54 0.0056
399 PEMPHIGOID 42 0.0056
400 PANCREATITIS 294 0.0056
401 EMPHYSEMA 56 0.0055
402 UNDERDOSE 405 0.0055
403 HYPOPHOSPHATAEMIA 41 0.0055
404 MICTURITION URGENCY 63 0.0055
405 FEELING HOT 338 0.0055
406 IMMOBILE 24 0.0055
407 GAIT DISTURBANCE 1051 0.0055
408 PYREXIA 1896 0.0055
409 MALAISE 2399 0.0055
410 FLUID RETENTION 278 0.0055
411 BENIGN PROSTATIC HYPERPLASIA 28 0.0054
412 PROCEDURAL PAIN 150 0.0054
413 EXERCISE TOLERANCE DECREASED 31 0.0054
414 ROSACEA 25 0.0054
415 PRODUCT USE IN UNAPPROVED INDICATION 1324 0.0053
416 HYPOCALCAEMIA 101 0.0053
417 ABDOMINAL PAIN 1229 0.0053
418 IMMUNE THROMBOCYTOPENIA 24 0.0052
419 LYME DISEASE 17 0.0051
420 OSTEOMYELITIS 92 0.0051
421 MYASTHENIA GRAVIS 41 0.0051
422 OSTEOPENIA 77 0.0051
423 TROPONIN INCREASED 38 0.0050
424 ANKLE FRACTURE 77 0.0050
425 VOMITING 2338 0.0050
426 NEPHROGENIC ANAEMIA 23 0.0050
427 AORTIC STENOSIS 17 0.0049
428 PRURITUS 1836 0.0048
429 BODY TEMPERATURE DECREASED 47 0.0048
430 LYMPHOEDEMA 33 0.0048
431 WEIGHT DECREASED 1326 0.0047
432 EATING DISORDER 100 0.0047
433 QUALITY OF LIFE DECREASED 63 0.0047
434 SKIN REACTION 66 0.0047
435 BLOOD POTASSIUM INCREASED 76 0.0047
436 HIP SURGERY 25 0.0046
437 DERMATITIS ALLERGIC 58 0.0046
438 HEADACHE 2871 0.0046
439 COMA 217 0.0046
440 DRY EYE 227 0.0045
441 COLITIS 171 0.0045
442 OFF LABEL USE 3948 0.0045
443 BLOOD URIC ACID INCREASED 26 0.0045
444 DIABETES MELLITUS 341 0.0045
445 VISUAL IMPAIRMENT 552 0.0044
446 BREAST CANCER STAGE I 41 0.0044
447 BONE DENSITY DECREASED 137 0.0044
448 DIZZINESS 2162 0.0043
449 GROIN PAIN 38 0.0043
450 DRUG INEFFECTIVE 5671 0.0043
451 ALANINE AMINOTRANSFERASE INCREASED 262 0.0043
452 FATIGUE 3315 0.0043
453 BRONCHITIS 313 0.0042
454 DIARRHOEA 2725 0.0042
455 SEROTONIN SYNDROME 81 0.0042
456 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
457 NOCTURIA 51 0.0042
458 DERMATITIS 88 0.0042
459 ASPARTATE AMINOTRANSFERASE INCREASED 223 0.0042
460 VEIN DISORDER 21 0.0042
461 NAUSEA 3306 0.0042
462 MOUTH ULCERATION 88 0.0042
463 DYSPNOEA 2356 0.0042
464 ORAL PAIN 93 0.0041
465 ANAPHYLACTIC REACTION 228 0.0041
466 DRUG ABUSE 343 0.0041
467 PRODUCT QUALITY ISSUE 558 0.0041
468 PSORIASIS 536 0.0041
469 LOCALISED INFECTION 99 0.0041
470 MUSCULOSKELETAL DISCOMFORT 70 0.0041
471 MULTIPLE DRUG OVERDOSE 20 0.0040
472 THROMBOSIS 323 0.0040
473 SKIN LESION 109 0.0040
474 BODY TEMPERATURE INCREASED 81 0.0040
475 ASTHENIA 1492 0.0040
476 PROTEINURIA 75 0.0039
477 LEUKOPENIA 196 0.0039
478 TOOTH INFECTION 51 0.0039
479 DEFAECATION URGENCY 27 0.0038
480 HAEMATOCHEZIA 211 0.0038
481 CYANOSIS 60 0.0038
482 SUBSTANCE ABUSE 31 0.0038
483 ATAXIA 44 0.0037
484 INCORRECT PRODUCT ADMINISTRATION DURATION 80 0.0037
485 PNEUMOCYSTIS JIROVECII PNEUMONIA 37 0.0037
486 TENDON DISORDER 24 0.0037
487 SPINAL OSTEOARTHRITIS 32 0.0036
488 UMBILICAL HERNIA 17 0.0036
489 PHOTOPHOBIA 68 0.0036
490 TACHYCARDIA 321 0.0036
491 SPINAL DISORDER 34 0.0036
492 ANXIETY 1016 0.0036
493 OROPHARYNGEAL DISCOMFORT 32 0.0035
494 NEURALGIA 86 0.0035
495 FOETAL EXPOSURE DURING PREGNANCY 284 0.0035
496 HYPOXIA 123 0.0035
497 DEEP VEIN THROMBOSIS 226 0.0035
498 PULMONARY EMBOLISM 327 0.0034
499 THYROID DISORDER 53 0.0034
500 ABDOMINAL TENDERNESS 17 0.0034
501 ABNORMAL FAECES 28 0.0034
502 END STAGE RENAL DISEASE 61 0.0033
503 HYPOKALAEMIA 154 0.0033
504 HAEMOGLOBIN DECREASED 342 0.0033
505 BLOOD CALCIUM INCREASED 29 0.0033
506 RALES 19 0.0033
507 GLAUCOMA 63 0.0033
508 HAEMOGLOBIN ABNORMAL 21 0.0033
509 HYPERLIPIDAEMIA 39 0.0033
510 CATARACT 193 0.0032
511 ERYTHEMA 660 0.0032
512 HERNIA 62 0.0032
513 UVEITIS 43 0.0032
514 LOSS OF CONSCIOUSNESS 406 0.0032
515 FAECES SOFT 23 0.0032
516 RESPIRATORY ARREST 87 0.0032
517 RED BLOOD CELL COUNT DECREASED 90 0.0031
518 PRODUCTIVE COUGH 150 0.0031
519 SEPTIC SHOCK 136 0.0031
520 MYDRIASIS 40 0.0031
521 BLOOD PRESSURE DIASTOLIC DECREASED 23 0.0031
522 LIVER FUNCTION TEST ABNORMAL 90 0.0031
523 CHOLECYSTECTOMY 35 0.0031
524 BLOOD IRON DECREASED 36 0.0030
525 CONJUNCTIVITIS 56 0.0030
526 APPENDICITIS 28 0.0030
527 MENINGITIS 20 0.0030
528 TOOTH FRACTURE 33 0.0030
529 HAEMOPTYSIS 83 0.0030
530 SEPSIS 331 0.0030
531 BLOOD CREATININE INCREASED 193 0.0030
532 GOUT 53 0.0030
533 HIATUS HERNIA 38 0.0029
534 DRUG ABUSER 18 0.0029
535 RESPIRATORY RATE INCREASED 26 0.0029
536 RENAL CYST 23 0.0029
537 NEOPLASM MALIGNANT 193 0.0029
538 SQUAMOUS CELL CARCINOMA 27 0.0029
539 PLEURISY 17 0.0029
540 POISONING DELIBERATE 27 0.0028
541 FRUSTRATION TOLERANCE DECREASED 23 0.0028
542 BACTERIAL INFECTION 53 0.0028
543 CENTRAL NERVOUS SYSTEM LESION 39 0.0028
544 INTENTIONAL PRODUCT MISUSE 247 0.0028
545 COLITIS ISCHAEMIC 19 0.0028
546 CARDIOVASCULAR DISORDER 71 0.0028
547 BLOOD TEST ABNORMAL 39 0.0028
548 TENDON PAIN 21 0.0028
549 RENAL IMPAIRMENT 232 0.0028
550 TREATMENT NONCOMPLIANCE 150 0.0027
551 PHARYNGEAL OEDEMA 42 0.0027
552 IRON DEFICIENCY ANAEMIA 25 0.0027
553 PLEURAL EFFUSION 163 0.0027
554 FEELING JITTERY 51 0.0027
555 VITAMIN D DEFICIENCY 26 0.0027
556 WHITE BLOOD CELL COUNT ABNORMAL 17 0.0027
557 PULMONARY CONGESTION 35 0.0027
558 CYSTITIS 84 0.0026
559 INTENTIONAL DRUG MISUSE 55 0.0026
560 THROAT TIGHTNESS 71 0.0026
561 TEMPERATURE INTOLERANCE 27 0.0026
562 PNEUMONIA BACTERIAL 24 0.0026
563 RESPIRATION ABNORMAL 18 0.0026
564 MULTIPLE FRACTURES 42 0.0026
565 COMPLETED SUICIDE 213 0.0026
566 FALL 848 0.0025
567 DIVERTICULUM 18 0.0025
568 SPUTUM DISCOLOURED 24 0.0025
569 BONE DISORDER 46 0.0025
570 MOVEMENT DISORDER 81 0.0025
571 HYPOAESTHESIA ORAL 38 0.0025
572 HOSPITALISATION 385 0.0025
573 INFLUENZA 279 0.0025
574 OVARIAN CYST 25 0.0025
575 NEPHROLITHIASIS 114 0.0025
576 BOWEL MOVEMENT IRREGULARITY 19 0.0025
577 POISONING 31 0.0025
578 DERMATITIS CONTACT 28 0.0025
579 EAR DISCOMFORT 25 0.0024
580 BLOOD MAGNESIUM DECREASED 21 0.0024
581 RENAL FAILURE 323 0.0024
582 FRACTURE 46 0.0024
583 IMMUNE SYSTEM DISORDER 32 0.0024
584 RASH ERYTHEMATOUS 116 0.0024
585 DUODENAL ULCER 17 0.0024
586 DRUG USE DISORDER 20 0.0024
587 EYE DISORDER 78 0.0024
588 TOXICITY TO VARIOUS AGENTS 398 0.0024
589 ACCIDENTAL OVERDOSE 86 0.0023
590 FEELING ABNORMAL 560 0.0023
591 ANAL INCONTINENCE 21 0.0023
592 ANAEMIA 442 0.0023
593 SECRETION DISCHARGE 29 0.0023
594 GALLBLADDER DISORDER 41 0.0023
595 BLOOD PRESSURE INCREASED 350 0.0023
596 BACK PAIN 528 0.0023
597 INTERVERTEBRAL DISC DEGENERATION 21 0.0023
598 PARANOIA 39 0.0023
599 GINGIVAL PAIN 18 0.0023
600 TOOTH ABSCESS 23 0.0023
601 SWELLING FACE 147 0.0023
602 GAMMA-GLUTAMYLTRANSFERASE INCREASED 50 0.0023
603 VENTRICULAR FIBRILLATION 25 0.0022
604 EUPHORIC MOOD 23 0.0022
605 BRAIN OEDEMA 28 0.0022
606 TOOTHACHE 40 0.0022
607 BLOOD PRESSURE FLUCTUATION 53 0.0022
608 NEUROPATHY PERIPHERAL 209 0.0022
609 SCAB 25 0.0022
610 HYPERAESTHESIA 18 0.0022
611 CONSTIPATION 474 0.0022
612 BRAIN FOG 34 0.0022
613 MUSCLE TIGHTNESS 35 0.0022
614 ARTHROPOD BITE 16 0.0022
615 GASTRIC ULCER 41 0.0022
616 LYMPHOCYTE COUNT DECREASED 38 0.0021
617 PLATELET COUNT INCREASED 28 0.0021
618 CAESAREAN SECTION 25 0.0021
619 EYE PAIN 121 0.0021
620 OVERDOSE 460 0.0021
621 HYPOTHYROIDISM 68 0.0021
622 FACIAL PAIN 19 0.0021
623 MYALGIA 358 0.0021
624 SLEEP APNOEA SYNDROME 40 0.0021
625 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
626 GASTRIC HAEMORRHAGE 24 0.0021
627 RESPIRATORY DISTRESS 57 0.0021
628 DRUG EFFECT DECREASED 111 0.0021
629 BODY HEIGHT DECREASED 22 0.0021
630 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
631 RASH PAPULAR 46 0.0021
632 INTENTIONAL OVERDOSE 131 0.0020
633 THERAPY CHANGE 20 0.0020
634 CARDIO-RESPIRATORY ARREST 85 0.0020
635 POOR VENOUS ACCESS 21 0.0020
636 CARDIAC FAILURE CONGESTIVE 163 0.0020
637 SKIN HAEMORRHAGE 30 0.0020
638 DYSARTHRIA 76 0.0020
639 POLLAKIURIA 84 0.0020
640 OESOPHAGITIS 22 0.0020
641 PAIN IN JAW 57 0.0020
642 WHITE BLOOD CELL COUNT DECREASED 218 0.0020
643 TOOTH EXTRACTION 25 0.0020
644 LYMPHADENOPATHY 71 0.0020
645 RESPIRATORY TRACT INFECTION 52 0.0020
646 NERVE INJURY 22 0.0020
647 UNRESPONSIVE TO STIMULI 51 0.0020
648 DRY THROAT 20 0.0020
649 PERIPHERAL COLDNESS 27 0.0020
650 SPINAL PAIN 23 0.0020
651 DISEASE RECURRENCE 93 0.0020
652 MULTIPLE ORGAN DYSFUNCTION SYNDROME 55 0.0019
653 THROMBOCYTOPENIA 217 0.0019
654 MUSCULOSKELETAL CHEST PAIN 30 0.0019
655 PALPITATIONS 227 0.0019
656 MUSCLE RIGIDITY 23 0.0019
657 OROPHARYNGEAL PAIN 178 0.0019
658 SOMNOLENCE 386 0.0019
659 SINUS TACHYCARDIA 27 0.0019
660 OCULAR HYPERAEMIA 90 0.0019
661 LOCAL SWELLING 33 0.0019
662 BALANCE DISORDER 163 0.0019
663 SCAR 32 0.0019
664 SMALL INTESTINAL OBSTRUCTION 23 0.0019
665 APHONIA 26 0.0019
666 HYPOKINESIA 27 0.0019
667 PRODUCT SUBSTITUTION ISSUE 107 0.0019
668 DECREASED ACTIVITY 20 0.0019
669 BURNING SENSATION 130 0.0019
670 MOOD SWINGS 59 0.0018
671 INCREASED TENDENCY TO BRUISE 17 0.0018
672 RENAL DISORDER 86 0.0018
673 MYOCLONUS 22 0.0018
674 PHARYNGEAL SWELLING 18 0.0018
675 DISEASE PROGRESSION 217 0.0018
676 DRUG RESISTANCE 47 0.0018
677 MUSCLE TWITCHING 42 0.0018
678 HAEMATOCRIT DECREASED 36 0.0018
679 IMPAIRED QUALITY OF LIFE 26 0.0018
680 EYE IRRITATION 104 0.0018
681 SALIVARY HYPERSECRETION 18 0.0018
682 DYSPHONIA 105 0.0018
683 COORDINATION ABNORMAL 25 0.0018
684 MASS 25 0.0018
685 SEASONAL ALLERGY 25 0.0018
686 OXYGEN SATURATION DECREASED 99 0.0018
687 LACRIMATION INCREASED 53 0.0018
688 TRANSAMINASES INCREASED 39 0.0018
689 TOOTH DISORDER 39 0.0018
690 FAECES DISCOLOURED 38 0.0018
691 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 91 0.0017
692 CANDIDA INFECTION 29 0.0017
693 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
694 THROAT IRRITATION 77 0.0017
695 COUGH 479 0.0017
696 URINARY TRACT INFECTION 291 0.0017
697 DISSEMINATED INTRAVASCULAR COAGULATION 24 0.0017
698 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
699 SKIN INFECTION 19 0.0017
700 MENTAL STATUS CHANGES 47 0.0017
701 AGEUSIA 42 0.0017
702 CARDIOGENIC SHOCK 24 0.0017
703 INJECTION SITE URTICARIA 41 0.0017
704 WRIST FRACTURE 20 0.0017
705 MOTOR DYSFUNCTION 17 0.0017
706 PHARYNGITIS STREPTOCOCCAL 18 0.0017
707 RIB FRACTURE 34 0.0017
708 PNEUMONITIS 45 0.0017
709 PLATELET COUNT DECREASED 176 0.0016
710 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
711 DYSSTASIA 48 0.0016
712 CARPAL TUNNEL SYNDROME 23 0.0016
713 TREMOR 272 0.0016
714 ELECTROLYTE IMBALANCE 19 0.0016
715 HYPONATRAEMIA 92 0.0016
716 RESPIRATORY DEPRESSION 20 0.0016
717 ABSCESS 26 0.0016
718 SINUS CONGESTION 22 0.0016
719 GLOMERULAR FILTRATION RATE DECREASED 20 0.0016
720 CARDIOMEGALY 20 0.0016
721 BLOOD UREA INCREASED 27 0.0016
722 CHILLS 189 0.0016
723 MIDDLE INSOMNIA 30 0.0016
724 ERECTILE DYSFUNCTION 41 0.0016
725 GASTRITIS 42 0.0016
726 SKIN DISCOLOURATION 73 0.0016
727 TRANSIENT ISCHAEMIC ATTACK 53 0.0016
728 CHOLELITHIASIS 51 0.0016
729 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 40 0.0016
730 ERUCTATION 30 0.0015
731 CARDIAC ARREST 128 0.0015
732 SUICIDE ATTEMPT 94 0.0015
733 NASAL CONGESTION 91 0.0015
734 BRONCHOSPASM 22 0.0015
735 DYSPNOEA EXERTIONAL 58 0.0015
736 ACUTE HEPATIC FAILURE 21 0.0015
737 LETHARGY 88 0.0015
738 STAPHYLOCOCCAL INFECTION 50 0.0015
739 MYOCARDIAL INFARCTION 264 0.0015
740 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
741 REBOUND EFFECT 17 0.0015
742 LIP SWELLING 50 0.0015
743 WITHDRAWAL SYNDROME 63 0.0015
744 IMPAIRED DRIVING ABILITY 17 0.0015
745 UNEVALUABLE EVENT 113 0.0015
746 HEART RATE DECREASED 52 0.0015
747 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
748 COLD SWEAT 26 0.0015
749 BLOOD URINE PRESENT 28 0.0015
750 DEPRESSED LEVEL OF CONSCIOUSNESS 58 0.0015
751 HEART RATE IRREGULAR 33 0.0015
752 THIRST 26 0.0015
753 GENERALISED OEDEMA 18 0.0015
754 HEART RATE INCREASED 144 0.0015
755 BEDRIDDEN 19 0.0014
756 CARDIAC FAILURE 116 0.0014
757 FEELING COLD 40 0.0014
758 HAEMORRHOIDS 28 0.0014
759 BLOOD SODIUM DECREASED 27 0.0014
760 DRUG EFFECT INCOMPLETE 52 0.0014
761 RESTLESS LEGS SYNDROME 26 0.0014
762 PANIC ATTACK 52 0.0014
763 FOOT FRACTURE 27 0.0014
764 ILLNESS 146 0.0014
765 LUNG INFECTION 22 0.0014
766 HEAD DISCOMFORT 25 0.0014
767 VERTIGO 86 0.0014
768 FLATULENCE 80 0.0014
769 URINARY RETENTION 47 0.0014
770 INTESTINAL OBSTRUCTION 53 0.0014
771 INJECTION SITE PRURITUS 94 0.0014
772 ROTATOR CUFF SYNDROME 18 0.0014
773 INFUSION SITE PAIN 18 0.0014
774 THINKING ABNORMAL 26 0.0014
775 ASCITES 41 0.0014
776 TINNITUS 64 0.0014
777 RHINORRHOEA 90 0.0014
778 BREAST CANCER 129 0.0014
779 VIRAL INFECTION 46 0.0014
780 PREMATURE DELIVERY 22 0.0014
781 DYSPHAGIA 130 0.0014
782 CHRONIC KIDNEY DISEASE 104 0.0014
783 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
784 ACUTE KIDNEY INJURY 209 0.0014
785 RETCHING 29 0.0014
786 HYPOTENSION 272 0.0014
787 ACUTE RESPIRATORY FAILURE 26 0.0014
788 COGNITIVE DISORDER 63 0.0013
789 BACTERAEMIA 16 0.0013
790 AGITATION 99 0.0013
791 SWOLLEN TONGUE 42 0.0013
792 FLUSHING 136 0.0013
793 MUCOSAL INFLAMMATION 35 0.0013
794 EMOTIONAL DISORDER 41 0.0013
795 THERAPY CESSATION 68 0.0013
796 BLOOD PRESSURE DECREASED 88 0.0013
797 PNEUMOTHORAX 21 0.0013
798 ANOREXIA 17 0.0013
799 EYE SWELLING 49 0.0013
800 BRADYCARDIA 69 0.0013
801 HYPOACUSIS 56 0.0013
802 DRUG INTERACTION 206 0.0013
803 DISTURBANCE IN ATTENTION 70 0.0013
804 BLOOD POTASSIUM DECREASED 39 0.0013
805 INFLUENZA LIKE ILLNESS 106 0.0013
806 SOPOR 17 0.0013
807 CELLULITIS 64 0.0013
808 PRODUCT USE COMPLAINT 20 0.0013
809 CRYING 46 0.0013
810 HYPERGLYCAEMIA 46 0.0013
811 FUNGAL INFECTION 42 0.0013
812 SKIN DISORDER 42 0.0013
813 APHASIA 38 0.0013
814 INJECTION SITE BRUISING 100 0.0013
815 DYSURIA 46 0.0012
816 HALLUCINATION, VISUAL 26 0.0012
817 CHOKING 24 0.0012
818 ORAL HERPES 24 0.0012
819 PULMONARY OEDEMA 55 0.0012
820 NEUTROPHIL COUNT DECREASED 50 0.0012
821 CARDIOMYOPATHY 18 0.0012
822 URINARY INCONTINENCE 36 0.0012
823 PALLOR 33 0.0012
824 SINUS DISORDER 24 0.0012
825 SURGERY 71 0.0012
826 SKIN CANCER 26 0.0012
827 RESTLESSNESS 44 0.0012
828 RESPIRATORY TRACT CONGESTION 19 0.0012
829 BONE PAIN 70 0.0012
830 VISION BLURRED 164 0.0012
831 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
832 CORONARY ARTERY DISEASE 36 0.0012
833 HYPERHIDROSIS 153 0.0012
834 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
835 NIGHTMARE 41 0.0012
836 ANGER 40 0.0012
837 ANOSMIA 17 0.0012
838 PERICARDIAL EFFUSION 27 0.0012
839 SPEECH DISORDER 61 0.0012
840 MULTI-ORGAN FAILURE 20 0.0012
841 PRURITUS GENERALISED 25 0.0012
842 MENTAL IMPAIRMENT 28 0.0012
843 DEHYDRATION 154 0.0012
844 HEPATIC FUNCTION ABNORMAL 43 0.0012
845 RESPIRATORY FAILURE 84 0.0012
846 COLON CANCER 17 0.0011
847 SUICIDAL IDEATION 104 0.0011
848 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
849 WRONG TECHNIQUE IN DRUG USAGE PROCESS 41 0.0011
850 SKIN EXFOLIATION 95 0.0011
851 INJECTION SITE SWELLING 86 0.0011
852 ATRIAL FIBRILLATION 109 0.0011
853 DIPLOPIA 29 0.0011
854 HYPERSOMNIA 32 0.0011
855 INSURANCE ISSUE 17 0.0011
856 MYELOSUPPRESSION 40 0.0011
857 DEPRESSED MOOD 58 0.0011
858 APATHY 16 0.0011
859 EPISTAXIS 82 0.0011
860 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
861 DRUG LEVEL INCREASED 18 0.0011
862 SHOCK 25 0.0011
863 HOT FLUSH 81 0.0011
864 HEAD INJURY 34 0.0011
865 BLOOD PRESSURE ABNORMAL 21 0.0011
866 CHEST DISCOMFORT 108 0.0011
867 MALIGNANT NEOPLASM PROGRESSION 108 0.0011
868 LEUKOCYTOSIS 19 0.0010
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 188 0.0010
870 FEAR 28 0.0010
871 AGGRESSION 52 0.0010
872 INJECTION SITE ERYTHEMA 128 0.0010
873 LIMB INJURY 28 0.0010
874 RASH MACULAR 36 0.0010
875 PRESYNCOPE 25 0.0010
876 ABDOMINAL PAIN LOWER 26 0.0010
877 POOR QUALITY SLEEP 22 0.0010
878 CHROMATURIA 23 0.0010
879 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
880 ANGINA PECTORIS 29 0.0010
881 MENTAL DISORDER 44 0.0010
882 INJECTION SITE RASH 31 0.0010
883 RENAL INJURY 30 0.0010
884 DISORIENTATION 40 0.0010
885 FACE OEDEMA 17 0.0010
886 MULTIPLE SCLEROSIS RELAPSE 69 0.0010
887 BLINDNESS 41 0.0010
888 APPLICATION SITE ERYTHEMA 26 0.0010
889 HYPOGLYCAEMIA 48 0.0010
890 PRODUCT DOSE OMISSION IN ERROR 28 0.0010
891 IRRITABILITY 59 0.0010
892 SEIZURE 113 0.0010
893 ENCEPHALOPATHY 24 0.0010
894 ABASIA 24 0.0010
895 INJECTION SITE PAIN 297 0.0010
896 COAGULOPATHY 16 0.0010
897 ISCHAEMIC STROKE 17 0.0010
898 STEVENS-JOHNSON SYNDROME 21 0.0009
899 ABNORMAL DREAMS 26 0.0009
900 MULTIPLE SCLEROSIS 45 0.0009
901 NERVOUSNESS 49 0.0009
902 INJECTION SITE WARMTH 19 0.0009
903 BLOOD GLUCOSE INCREASED 172 0.0009
904 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
905 FEMUR FRACTURE 28 0.0009
906 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
907 SPINAL FRACTURE 18 0.0009
908 GASTROINTESTINAL HAEMORRHAGE 75 0.0009
909 NERVOUS SYSTEM DISORDER 28 0.0009
910 RENAL FAILURE ACUTE 38 0.0009
911 PANCREATITIS ACUTE 20 0.0009
912 HAEMATOMA 23 0.0009
913 PSYCHOTIC DISORDER 26 0.0009
914 PRODUCT PREPARATION ERROR 18 0.0009
915 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
916 SYNCOPE 87 0.0009
917 KIDNEY INFECTION 17 0.0009
918 HALLUCINATION 65 0.0009
919 PAIN OF SKIN 23 0.0009
920 RASH GENERALISED 22 0.0008
921 SNEEZING 19 0.0008
922 PANCYTOPENIA 47 0.0008
923 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
924 CARDIAC DISORDER 78 0.0008
925 ABNORMAL BEHAVIOUR 33 0.0008
926 HEPATIC FAILURE 25 0.0008
927 FEBRILE NEUTROPENIA 55 0.0008
928 HAEMATEMESIS 21 0.0008
929 NO ADVERSE EVENT 150 0.0008
930 HYPERKALAEMIA 29 0.0008
931 PRODUCT PRESCRIBING ISSUE 18 0.0008
932 TOOTH LOSS 17 0.0008
933 CEREBRAL INFARCTION 20 0.0008
934 PULMONARY HYPERTENSION 17 0.0008
935 METABOLIC ACIDOSIS 26 0.0008
936 COVID-19 141 0.0008
937 ECZEMA 42 0.0008
938 DYSGEUSIA 58 0.0008
939 JAUNDICE 21 0.0008
940 THERAPEUTIC RESPONSE UNEXPECTED 35 0.0008
941 ANAPHYLACTIC SHOCK 20 0.0008
942 DYSKINESIA 31 0.0008
943 HAEMATURIA 26 0.0008
944 INJECTION SITE MASS 28 0.0008
945 VISUAL ACUITY REDUCED 25 0.0008
946 HAEMORRHAGE 78 0.0007
947 EYE PRURITUS 25 0.0007
948 PRODUCT DOSE OMISSION ISSUE 216 0.0007
949 OSTEONECROSIS 24 0.0007
950 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
951 ARRHYTHMIA 34 0.0007
952 HIP FRACTURE 23 0.0007
953 INJECTION SITE HAEMORRHAGE 57 0.0007
954 BREAST CANCER FEMALE 19 0.0007
955 PRODUCT COMPLAINT 18 0.0007
956 CEREBROVASCULAR ACCIDENT 120 0.0007
957 BLOOD GLUCOSE DECREASED 34 0.0007
958 LUNG NEOPLASM MALIGNANT 28 0.0007
959 INCORRECT DRUG ADMINISTRATION DURATION 19 0.0007
960 INTENTIONAL DOSE OMISSION 19 0.0007
961 DEATH 572 0.0007
962 NEEDLE ISSUE 19 0.0007
963 CONVULSION 37 0.0006
964 ANHEDONIA 17 0.0006
965 DRY SKIN 86 0.0006
966 THERAPY INTERRUPTED 46 0.0006
967 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
968 PREMATURE BABY 19 0.0006
969 BLOOD BILIRUBIN INCREASED 17 0.0006
970 INCORRECT DOSE ADMINISTERED 142 0.0006
971 DEMENTIA 17 0.0006
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 42 0.0006
973 ANGIOEDEMA 26 0.0006
974 NEUTROPENIA 78 0.0006
975 SKIN IRRITATION 25 0.0005
976 DRUG DOSE OMISSION 88 0.0005
977 PRODUCT DOSE OMISSION 34 0.0005
978 RHABDOMYOLYSIS 21 0.0005
979 DRUG WITHDRAWAL SYNDROME 44 0.0005
980 DEVICE MALFUNCTION 35 0.0005
981 CEREBRAL HAEMORRHAGE 17 0.0005
982 SKIN BURNING SENSATION 33 0.0005
983 DRUG DEPENDENCE 73 0.0005
984 ABORTION SPONTANEOUS 18 0.0004
985 EMOTIONAL DISTRESS 54 0.0004
986 DEVICE DISLOCATION 19 0.0004
987 PLASMA CELL MYELOMA 17 0.0004
988 ACNE 33 0.0004
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 55 0.0003
990 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
991 DEVICE ISSUE 18 0.0002